Literature DB >> 11339776

Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol.

J E Reid1, D S Breslin, R K Mirakhur, A H Hayes.   

Abstract

PURPOSE: To examine the influence of continuing administration of sevoflurane or isoflurane during reversal of rocuronium induced neuromuscular block with neostigmine.
METHODS: One hundred and twenty patients, divided into three equal groups, were randomly allocated to maintenance of anesthesia with sevoflurane, isoflurane or propofol. Neuromuscular block was induced with rocuronium and monitored using train-of-four (TOF) stimulation of the ulnar nerve and recording the force of contraction of the adductor pollicis muscle. Neostigmine was administered when the first response in TOF had recovered to 25%. At this time the volatile agent administration was stopped or propofol dosage reduced in half the patients in each group (n = 20 in each group). The times to attain TOF ratio of 0.8, and the number of patients attaining this end point within 15 min were recorded.
RESULTS: The times (mean +/- SD) to recovery of the TOF ratio to 0.8 were 12.0 +/- 5.5 and 6.8 +/- 2.3 min in the sevoflurane continued and sevoflurane stopped groups, 9.0 +/- 8.3 and 5.5 +/- 3.0 min in the isoflurane continued and isoflurane stopped groups, and 5.2 +/- 2.8 and 4.7 +/- 1.5 min in the propofol continued and propofol stopped groups (P < 0.5-01). Only 9 and 15 patients in the sevoflurane and isoflurane continued groups respectively had attained a TOF ratio of 0.8 within 15 min (P < 0.001 for sevoflurane).
CONCLUSIONS: The continued administration of sevoflurane, and to a smaller extent isoflurane, results in delay in attaining adequate antagonism of rocuronium induced neuromuscular block.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11339776     DOI: 10.1007/BF03014962

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  9 in total

1.  Rocuronium: automatic infusion versus manual administration with TOF monitorisation.

Authors:  Fatma Gulcin Ozturk Arikan; Guldem Turan; Asu Ozgultekin; Zubeyir Sivrikaya; Bekir Cem Cosar; Dondu Nisa Onder
Journal:  J Clin Monit Comput       Date:  2015-08-18       Impact factor: 2.502

Review 2.  Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.

Authors:  Ana-Marija Hristovska; Patricia Duch; Mikkel Allingstrup; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2017-08-14

Review 3.  Sugammadex: a review of its use in anaesthetic practice.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Reversal by sugammadex.

Authors:  Pramila Bajaj
Journal:  Indian J Anaesth       Date:  2009-08

5.  Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine.

Authors:  Hendrikus Jm Lemmens; Mohammad I El-Orbany; James Berry; Jovino Ben Morte; Gavin Martin
Journal:  BMC Anesthesiol       Date:  2010-09-01       Impact factor: 2.217

6.  Use of neuromuscular blockers and neostigmine for general anesthesia and its association with neuraxial blockade: A retrospective study.

Authors:  Filipe Nadir Caparica Santos; Angélica de Fátima de Assunção Braga; Fernando Eduardo Feres Junqueira; Rafaela Menezes Bezerra; Felipe Ferreira de Almeida; Franklin Sarmento da Silva Braga; Vanessa Henriques Carvalho
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

7.  Comparison of recovery after sugammadex or neostigmine reversal of rocuronium in geriatric patients undergoing spine surgery: a randomized controlled trial.

Authors:  Boris Mraovic; Noah J Timko; Theodore J Choma
Journal:  Croat Med J       Date:  2021-12-31       Impact factor: 1.351

Review 8.  Sugammadex: Appropriate Use in the Context of Budgetary Constraints.

Authors:  Guy Cammu
Journal:  Curr Anesthesiol Rep       Date:  2018-03-20

9.  Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors.

Authors:  Thuy Luu Quang; Huyen Nguyen Thi Thu; Kinh Nguyen Quoc; Ha Nguyen Thu; Dong Pham Van; Nguyen Le Bao Tien; Vo Van Thanh; Vu Thi Nga; Chu Dinh Toi
Journal:  Open Access Maced J Med Sci       Date:  2019-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.